Vista Investment Partners LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) in the 3rd quarter, Holdings Channel.com reports. The fund acquired 8,526 shares of the insurance provider’s stock, valued at approximately $3,254,000.
A number of other institutional investors have also recently made changes to their positions in HUM. BlackRock Inc. bought a new stake in Humana in the 2nd quarter worth approximately $4,138,160,000. Pzena Investment Management LLC grew its holdings in shares of Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after purchasing an additional 1,398,774 shares in the last quarter. Legal & General Group Plc bought a new stake in Humana in the second quarter worth $329,760,000. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in Humana in the second quarter worth $314,922,000. Finally, Wellington Management Group LLP raised its stake in Humana by 7.3% during the second quarter. Wellington Management Group LLP now owns 765,355 shares of the insurance provider’s stock valued at $304,014,000 after purchasing an additional 52,004 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have commented on HUM shares. Raymond James Financial set a $460.00 price objective on shares of Humana in a research report on Wednesday. Deutsche Bank Aktiengesellschaft started coverage on Humana in a research report on Thursday, July 30th. They issued a “hold” rating for the company. Cantor Fitzgerald raised Humana from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $300.00 to $460.00 in a research note on Wednesday. JPMorgan Chase & Co. upped their price objective on Humana from $316.00 to $393.00 and gave the company a “neutral” rating in a research report on Monday, August 10th. Finally, Piper Sandler upgraded Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price for the company in a report on Thursday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $422.52.
Humana Trading Down 3.2%
HUM traded down $12.83 during trading hours on Thursday, reaching $383.68. 1,196,156 shares of the company’s stock traded hands, compared to its average volume of 1,642,109. The firm has a 50-day moving average price of $386.84 and a 200 day moving average price of $331.34. The firm has a market capitalization of $46.07 billion, a PE ratio of 36.30, a PEG ratio of 2.49 and a beta of 0.74. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.
Humana (NYSE:HUM – Get Free Report) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same period last year, the company earned $6.27 earnings per share. The business’s revenue for the quarter was up 26.2% compared to the same quarter last year. As a group, sell-side analysts predict that Humana Inc. will post 9.01 EPS for the current fiscal year.
Humana Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be paid a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana’s dividend payout ratio is 33.49%.
About Humana
Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.
Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.
Further Reading
- Five stocks we like better than Humana
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
- This Space ETF Offers SpaceX Exposure—But Investors Are Paying for the Volatilit
- Does Lemonade’s Growth Signal Profits Ahead?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
